Search hospitals > Florida > Fort Lauderdale
UM Sylvester Comprehensive Cancer Center at Plantation
Claim this profileFort Lauderdale, Florida 33324
Global Leader in Skin Cancer
Global Leader in Cancer
Conducts research for Relapse
Conducts research for Uterine Tumors
Conducts research for Lung Cancer
93 reported clinical trials
42 medical researchers
Summary
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Skin Cancer, Cancer, Relapse, Uterine Tumors, Lung Cancer and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 220 conditions. There are 42 research doctors associated with this hospital, such as Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, Aman Chauhan, MD, and Macarena I. De La Fuente.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
BRAF positive
2Cancer
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Jose Lutzky, MDUniversity of Miami4 years of reported clinical research
Expert in Skin Cancer
Studies Melanoma
20 reported clinical trials
40 drugs studied
Chukwuemeka (Emeka) V. IkpeazuUniversity of Miami Miller School of Medicine-Sylvester Cancer Center2 years of reported clinical research
Studies Skin Cancer
Studies Cancer
13 reported clinical trials
34 drugs studied
Aman Chauhan, MDUniversity of Kentucky/Markey Cancer Center2 years of reported clinical research
Studies Neuroendocrine Tumors
Studies Carcinoid Tumor
12 reported clinical trials
20 drugs studied
Macarena I. De La FuenteUniversity of Miami Miller School of Medicine-Sylvester Cancer Center5 years of reported clinical research
Studies Brain Tumor
Studies Cerebral Gliomas
12 reported clinical trials
27 drugs studied
Clinical Trials running at UM Sylvester Comprehensive Cancer Center at Plantation
Skin Cancer
Breast Cancer
Lung Cancer
Cancer
Cutaneous Melanoma
Prostate Cancer
Gallbladder Cancer
Uterine Tumors
Ovarian Cancer
Non-Small Cell Lung Cancer
Pump Chemotherapy
for Colorectal Cancer
This phase III trial compares hepatic arterial infusion (HAI) (pump chemotherapy) in addition to standard of care chemotherapy versus standard of care chemotherapy alone in treating patients with colorectal cancer that has spread to the liver (liver metastases) and cannot be removed by surgery (unresectable). HAI uses a catheter to carry a tumor-killing chemotherapy drug called floxuridine directly into the liver. HAI is already approved by the Food and Drug Administration (FDA) for use in metastatic colorectal cancer to the liver, but it is only available at a small number of hospitals, and most of the time it is not used until standard chemotherapy stops working. Standard chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding HAI to standard chemotherapy may be effective in shrinking or stabilizing unresectable colorectal liver metastases.
Recruiting2 awards Phase 37 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UM Sylvester Comprehensive Cancer Center at Plantation?
UM Sylvester Comprehensive Cancer Center at Plantation is a medical facility located in Fort Lauderdale, Florida. This center is recognized for care of Skin Cancer, Cancer, Relapse, Uterine Tumors, Lung Cancer and other specialties. UM Sylvester Comprehensive Cancer Center at Plantation is involved with conducting 93 clinical trials across 220 conditions. There are 42 research doctors associated with this hospital, such as Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, Aman Chauhan, MD, and Macarena I. De La Fuente.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.